422 filings
Page 17 of 22
8-A12B
9drkklnjkazd
19 Feb 09
Registration of securities on exchange
12:00am
8-K
4di75k3 d1s
19 Feb 09
Regulation FD Disclosure
12:00am
425
x0jf8bo
17 Feb 09
Business combination disclosure
12:00am
425
vna1gbup5sosgee3
17 Feb 09
Business combination disclosure
12:00am
425
erkhk ddn
13 Feb 09
Business combination disclosure
12:00am
8-K
2rgjc08xte yr
13 Feb 09
Combined Company Will Offer Broad Portfolio of Devices to Improve Therapies for Heart Failure Patients
12:00am
425
lmt0f
13 Feb 09
Business combination disclosure
12:00am
425
0915tq8
13 Feb 09
Business combination disclosure
12:00am
8-K
g06jg bbfujw7
13 Feb 09
Entry into a Material Definitive Agreement
12:00am
425
88u5l iex
13 Feb 09
Business combination disclosure
12:00am
425
xrxvexw0 8o8t7
13 Feb 09
Business combination disclosure
12:00am
425
snvpv
13 Feb 09
Business combination disclosure
12:00am
8-K
yw6nluk9
9 Feb 09
Regulation FD Disclosure
12:00am
8-K
ctmt4 5caog
6 Feb 09
Keith Aaronson, M.D. appointed Co-Principal Investigator of HeartWare Clinical Trial
12:00am
8-K
uoxehw1vpvxefic92em8
30 Jan 09
HeartWare Receives CE Mark Approval for Miniaturized Heart Pump System
12:00am
8-K
8rgiod2ni
30 Jan 09
Results of Operations and Financial Condition
12:00am
8-K
5qi53schfvr7xnz
16 Dec 08
Mark Slaughter, M.D. appointed Principal Investigator of HeartWare Clinical Trial
12:00am
8-K
hp6e8t5mlyghkrqw5
5 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
ajs275t
4 Dec 08
Successful Completion of International Clinical Trial 50 Patients Enrolled
12:00am